Publication | Closed Access

Th1 responses to beta-amyloid in young humans convert to regulatory IL-10 responses in Down syndrome and Alzheimer's disease

Down SyndromeRegulatory Il-10 ResponsesAlzheimer's DiseaseAutoimmune DiseaseMedicineYoung HumansImmunologyAutoimmunityNeurochemical BiomarkersNeuroscienceNeurologyNeurodegenerationNeuroimmunologyNeuroinflammation